<- Go Home
IMARA Inc.
As of February 23, 2023, IMARA Inc. was acquired by Enliven Therapeutics, Inc., in a reverse merger transaction. IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.
Market Cap
$165.8M
Volume
260.0K
Cash and Equivalents
$88.2M
EBITDA
-$33.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$25.28
52 Week Low
$3.90
Dividend
N/A
Price / Book Value
1.84
Price / Earnings
111.65
Price / Tangible Book Value
1.84
Enterprise Value
$77.6M
Enterprise Value / EBITDA
-2.31
Operating Income
-$34.3M
Return on Equity
1.69%
Return on Assets
-23.08
Cash and Short Term Investments
$88.2M
Debt
N/A
Equity
$90.1M
Revenue
N/A
Unlevered FCF
-$22.7M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium